It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Both γδ T cells and CD4+ T cells have been implicated in immunity to malaria, but their association with natural gain or loss of infection has not been studied before. Therefore, we followed up asymptomatic children living in an area endemic for malaria in Indonesia for 21 months. The percentage of γδ T cells was related to both current and previous infection, with higher percentages in infected than uninfected children and declining after infections resolve. Infected children also had higher levels of Th1 and Th17 cells, lower levels of CD25Hi FOXP3+ regulatory T cells (Tregs), but similar levels of Th2 cells as compared to uninfected children. However, TNF, IFN-γ, and IL-17 cytokine responses to Plasmodium falciparum-infected red blood cells (PfRBCs) were similar, while IL-5 and IL-13 responses were lower in infected children. Furthermore, infected children had more phenotypically exhausted PD-1+ CD4+ T cells, more Tregs expressing TNF-RII, and higher IL-10 responses to PfRBCs, which persisted following resolution of infection. Altogether, this study demonstrates that asymptomatic malaria infection is associated with some long-lasting changes in the frequencies and immunoregulation of circulating innate and adaptive T cells, which might in part explain how pre-exposure to malaria affects responses to subsequent immunological challenges.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Leiden Immunoparasitology Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
2 Leiden Immunoparasitology Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands; Department of Medical Microbiology & Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands
3 Leiden Immunoparasitology Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands; Department of Parasitology, University of Indonesia, Jakarta Pusat, Indonesia
4 Leiden Immunoparasitology Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands; Department of Microbiology, Hasanuddin University, Makassar, Indonesia
5 Department of Parasitology, University of Indonesia, Jakarta Pusat, Indonesia
6 Mère et Enfant Face aux Infections Tropicales, UMR 216, French National Research Institute for Sustainable Development (IRD), Paris, France; Faculty of Pharmaceutical and Biological Sciences of Paris, Paris Descartes University, Paris, France